- Home
- QD vs CRMD Comparison
QD vs CRMD Comparison
Compare QD & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QD
- CRMD
- Stock Information
- Founded
- QD 2014
- CRMD 2006
- Country
- QD China
- CRMD United States
- Employees
- QD N/A
- CRMD N/A
- Industry
- QD Finance: Consumer Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- QD Finance
- CRMD Health Care
- Exchange
- QD Nasdaq
- CRMD Nasdaq
- Market Cap
- QD 761.2M
- CRMD 876.7M
- IPO Year
- QD 2017
- CRMD 2010
- Fundamental
- Price
- QD $4.40
- CRMD $9.68
- Analyst Decision
- QD
- CRMD Strong Buy
- Analyst Count
- QD 0
- CRMD 7
- Target Price
- QD N/A
- CRMD $17.43
- AVG Volume (30 Days)
- QD 303.4K
- CRMD 3.1M
- Earning Date
- QD 11-21-2025
- CRMD 11-12-2025
- Dividend Yield
- QD N/A
- CRMD N/A
- EPS Growth
- QD N/A
- CRMD N/A
- EPS
- QD 0.42
- CRMD 2.25
- Revenue
- QD $19,058,373.00
- CRMD $214,303,672.00
- Revenue This Year
- QD N/A
- CRMD $565.64
- Revenue Next Year
- QD N/A
- CRMD $46.09
- P/E Ratio
- QD $10.35
- CRMD $4.30
- Revenue Growth
- QD N/A
- CRMD 1647.67
- 52 Week Low
- QD $2.04
- CRMD $5.60
- 52 Week High
- QD $5.08
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- QD 47.73
- CRMD 36.60
- Support Level
- QD $4.36
- CRMD $9.45
- Resistance Level
- QD $4.95
- CRMD $10.40
- Average True Range (ATR)
- QD 0.22
- CRMD 0.67
- MACD
- QD -0.05
- CRMD -0.14
- Stochastic Oscillator
- QD 31.88
- CRMD 10.03
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.